Medical Diagnostech
Medical Diagnostech (Pty) Ltd is a Cape Town-based developer and manufacturer of lateral flow rapid diagnostic test kits covering HIV, malaria, COVID-19, pregnancy, drug abuse, and dengue, sold to healthcare providers, consumers, and B2B contract manufacturing clients across Africa since 2010.
- Company typePrivate
- Founded2010
- HeadquartersCape Town, South Africa
- Headcount11–50
- GTM typeB2B and B2C
- OfferingHardware or Manufacturing
What Medical Diagnostech does
Medical Diagnostech (Pty) Ltd, founded in 2010 by Ashley Uys and headquartered in Brackengate Business Park, Cape Town, is a privately held South African developer and manufacturer of lateral flow rapid diagnostic test kits. The company produces a broad product portfolio spanning HIV, malaria (Plasmodium falciparum, Pf/PAN, and P. vivax variants), COVID-19 (antigen and IgG/IgM), drugs of abuse (multi-panel tests for up to 14 substances), saliva alcohol, pregnancy, ovulation, syphilis, and dengue tests — sold in both professional-use bulk kit configurations (kits of 20-25 tests) and individual self-test formats. The underlying technology is lateral flow immunoassay using proprietary trade secret formulations, including a gold nanoparticle conjugation developed in-house, which the company claims cannot be reverse engineered and provides increased sensitivity, specificity, and shelf stability of up to 24 months under extreme storage conditions.
The business operates on a dual revenue model: (1) direct sales of in-house diagnostic kits to healthcare providers, pharmacies, and individual consumers through both B2B engagement and its own e-commerce-enabled website, and (2) contract manufacturing and custom R&D services for third parties developing new lateral flow components, test kits, sanitizers, and surgical scrubs. Products are manufactured under ISO 13485 accreditation (ISO Certificate 2022) and distributed under a SAHPRA license for the South African market. The company's customer base spans three horizontal segments — professional healthcare providers, individual self-test consumers, and B2B contract manufacturing partners.
The company remains founder-led, with Ashley Uys (BSc Hons Biotechnology, UWC) as Founder and CEO and Dr. Lyndon Mungur (PhD Biotechnology, UWC) as COO and shareholder since inception. It employs 11-50 staff, with R&D, manufacturing, quality assurance, and finance functions all based in Cape Town. Medical Diagnostech is a founding member of the Western Cape Medical Device Cluster and was recognised with the SAB Foundation Innovation Award for its malaria product. Operating geographies are concentrated in Africa, with management claiming a rapidly growing local and international client base.
Medical Diagnostech firmographics
Firmographics- Name
- Medical Diagnostech
- Legal name
- Medical Diagnostech (Pty) Ltd.
- Website
- https://medi-tech.co.za
- Company type
- Private
- Founded year
- 2010
- Operating status
- Operating
- Headcount range
- 11–50 employees
- Short description
- Medical Diagnostech (Pty) Ltd is a Cape Town-based developer and manufacturer of lateral flow rapid diagnostic test kits covering HIV, malaria, COVID-19, pregnancy, drug abuse, and dengue, sold to healthcare providers, consumers, and B2B contract manufacturing clients across Africa since 2010.
- Ownership category
- akta.pro rank
Medical Diagnostech industry classification
Industry- Product category
- In-Vitro Diagnostic Devices
- NAICS
- In-Vitro Diagnostic Substance Manufacturing (325413)
- SIC
- In Vitro & In Vivo Diagnostic Substances (2835), Surgical & Medical Instruments & Apparatus (3841)
- akta.pro primary industry
- Rapid Antigen/Antibody Lateral Flow Tests (General Platform Category) (HLAHAOAH)
- akta.pro secondary industries
- Home-Use & OTC Rapid Self-Tests (Consumer POCT kits) (HLAHAOAK), Home Diagnostic & Self-Test OTC Kits (HLAIADAO)
Keywords
Where Medical Diagnostech is headquartered
LocationHeadquarters
- HQ city
- Cape Town
- HQ country
- South Africa
- HQ region
- Africa
Offices1 record
Markets served
Medical Diagnostech business model
Business model- GTM type
- B2B and B2C
- Offering type
- Hardware or Manufacturing
- Cost components
- Personnel, Supply Chain, Operations, Technology or R&D, Marketing or Sales, Infrastructure
Revenue model
- Diagnostic Test Kit Sales: Sale of lateral flow rapid diagnostic test kits for alcohol, drugs of abuse, HIV, malaria, pregnancy, fertility/ovulation, COVID-19, syphilis, and dengue. Products sold in various formats including professional use kits and self-test kits.
- Contract Manufacturing and Development Services: R&D scientists work alongside customers through each stage of development, providing regular updates, advice and joint troubleshooting strategies for new innovative lateral flow components, test kits, and other medical related products including sanitizers and surgical scrubs.
Pricing tiers
| Model | Billing | Price |
|---|---|---|
| Unit Pricing | Pay-as-you-go | Professional use diagnostic test kits |
Go-to-market motion1 record
Distribution channels2 records
Marketing channels3 records
Medical Diagnostech product offering
Product offeringCore offering
Medical Diagnostech (Pty) Ltd. develops and manufactures lateral flow rapid diagnostic test kits for alcohol, drugs of abuse, HIV, malaria, pregnancy, fertility/ovulation, COVID-19, syphilis, and dengue, sold as professional-use kits and self-tests. The company also offers contract manufacturing and development services for new lateral flow components, test kits, and other medical products including sanitizers and surgical scrubs, working alongside customers through feasibility, optimization, and validation phases.
Product overview
Medical Diagnostech is a manufacturer and developer of lateral flow rapid diagnostic test kits, established in 2010. The company produces a comprehensive portfolio of rapid diagnostic products across multiple categories: COVID-19 tests (antigen self-tests, antigen professional tests, IgG/IgM rapid screen tests), HIV tests (self-test and professional whole blood/serum/plasma versions), Malaria tests (Plasmodium falciparum, Pf/PAN combinations, and Plasmodium vivax variants in both self-test and professional formats), drug of abuse tests (saliva alcohol test, 5-panel drug self-test, professional multi-panel drug tests detecting up to 14 substances), pregnancy tests (strip and midstream formats), ovulation tests, syphilis tests, and Dengue NS1 + IgG/IgM tests. All lateral flow tests are manufactured under ISO 13485 accreditation with claimed trade secret methodology for increased sensitivity and stability up to 24 months. The company also offers contract manufacturing and product development services including feasibility studies, optimization, and validation support.
Differentiator
Problem solved
Functional benefit
Products and services
- Pregnancy Strip Test Lateral flow test strip for the qualitative detection of human chorionic gonadotrophin (hCG) hormone to determine pregnancy, sold as a self-test product.
- MD Midstream Pregnancy Test
Quantifiable outcome
- Products tested and validated internationally to conform to most demanding standards
- +1 more outcomes
Companies that use Medical Diagnostech
Customer profileNamed customers1 record
Segments3 records
Ideal customer profiles3 records
Medical Diagnostech technology and API
TechnologyTechnology focussed Yes
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Feature3 records
Medical Diagnostech partnerships and signals
Strategic signalPartnerships
One partnership is on record.
- Western Cape Medical Device ClustercoreMedical Diagnostech is a founding member of the Western Cape Medical Device Cluster, a collaborative initiative connecting medical device companies in the Western Cape region of South Africa.
Scale indicators3 records
Recent moves6 records
Expansion highlights5 records
Medical Diagnostech competitors and assessment
Company assessmentBroad incumbents
- QuidelOrtho: Major US diagnostics company offering Sofia rapid antigen tests, Triage products, and a broad lateral flow portfolio. Comparable technology platform and overlapping infectious disease tests, but operates at incumbent scale across many geographies.
- Trinity Biotech: Ireland-based diagnostics company with a lateral flow and infectious disease product portfolio including HIV and syphilis rapid tests. Comparable technology base and product overlap, though Trinity is a larger, publicly listed incumbent.
- Abbott (Rapid Diagnostics / Alere heritage): Global diagnostics leader offering BinaxNOW COVID, Determine HIV, and a broad rapid test portfolio across professional and self-test channels. Overlaps heavily with Medical Diagnostech's product categories but at vastly larger scale and global distribution.
Direct peers
- SD Biosensor: South Korean manufacturer of lateral flow rapid diagnostic tests including COVID-19, influenza, HIV, and drugs-of-abuse panels. Directly comparable as a global lateral flow OEM with overlapping product categories and similar immunoassay-based technology stack.
- OraSure Technologies: US-based developer of rapid diagnostics including the OraQuick HIV self-test and drugs-of-abuse products. Directly comparable as a lateral flow specialist with strong self-test positioning in HIV and substance use.
- ACON Laboratories: US-based developer and manufacturer of rapid diagnostic tests including HIV self-tests, pregnancy, drugs-of-abuse, and infectious disease lateral flow panels. Closely comparable product mix (consumer self-tests plus professional kits) and B2B distribution model.
- Chembio Diagnostics: US-based developer of point-of-care lateral flow diagnostics including HIV, syphilis, and fever-disease multiplex tests. Comparable as a niche lateral flow specialist focused on infectious disease with both self-test and professional offerings.
- Hangzhou AllTest Biotech: Chinese lateral flow IVD manufacturer with broad infectious disease, fertility, and drugs-of-abuse rapid test catalog. Comparable as a contract manufacturer and finished-kit supplier serving emerging markets with similar price-sensitive positioning.
- Premier Biotech: US manufacturer of drugs-of-abuse and pregnancy rapid tests sold primarily into workplace, clinical, and at-home channels. Comparable as a focused lateral flow OEM in overlapping end markets with a contract manufacturing service line.
Regional players
- Meril Diagnostics: Indian IVD manufacturer producing rapid lateral flow tests for infectious disease, fertility, and drugs of abuse. Comparable product portfolio and emerging-market focus, primarily serving Asia and Africa but not South Africa directly.
Market position
Strengths5 records
Weaknesses5 records
Competitive moat4 records
Key risks6 records
Key highlights7 records
Customer concentration
Medical Diagnostech social profiles
Digital presenceMedical Diagnostech compliance and trust
Trust signalCompliance2 records
Medical Diagnostech financial estimates
Financial estimateRevenue estimate
Valuation estimate
Medical Diagnostech leadership team
Management profileNumber of profiles
Profiles9 records
Medical Diagnostech funding detail
Funding detailFunding overview
Funding rounds1 record
Investors1 record
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Medical Diagnostech M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Medical Diagnostech
What does Medical Diagnostech do?
Medical Diagnostech (Pty) Ltd. develops and manufactures lateral flow rapid diagnostic test kits for alcohol, drugs of abuse, HIV, malaria, pregnancy, fertility/ovulation, COVID-19, syphilis, and dengue, sold as professional-use kits and self-tests. The company also offers contract manufacturing and development services for new lateral flow components, test kits, and other medical products including sanitizers and surgical scrubs, working alongside customers through feasibility, optimization, and validation phases.
Is Medical Diagnostech a public or private company?
Medical Diagnostech is a private company. It is classified as founder individual operated bootstrapped and is currently operating.
When was Medical Diagnostech founded?
Medical Diagnostech was founded in 2010. It employs 11 to 50 people.
Where is Medical Diagnostech based?
Medical Diagnostech is headquartered in Cape Town, South Africa, in the Africa region.
How does Medical Diagnostech make money?
Two revenue lines are on record. Diagnostic Test Kit Sales are the primary driver. The others are contract Manufacturing and Development Services.
Who are Medical Diagnostech's main competitors?
Broad incumbents on record are QuidelOrtho, Trinity Biotech and Abbott (Rapid Diagnostics / Alere heritage). Direct peers are SD Biosensor, OraSure Technologies, ACON Laboratories, Chembio Diagnostics, Hangzhou AllTest Biotech and Premier Biotech. Meril Diagnostics is listed as a regional player.
Does Medical Diagnostech have an API?
No public API is recorded for Medical Diagnostech.
What industry is Medical Diagnostech in?
Medical Diagnostech's product category is In-Vitro Diagnostic Devices. Its primary akta.pro industry code is HLAHAOAH, Rapid Antigen/Antibody Lateral Flow Tests (General Platform Category), with a secondary code of HLAHAOAK, Home-Use & OTC Rapid Self-Tests (Consumer POCT kits). Its NAICS code is 325413 and its SIC code is 2835.